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Abstract
There exist two isoforms of cytosolic phosphoenolpyruvate carboxykinase (PEPCK-C) in
pig populations that differ in a single amino acid (Met139Leu). The isoenzymes have differ-
ent kinetic properties, affecting more strongly the Km and Vmax of nucleotides. They are
associated to different phenotypes modifying traits of considerable economic interest. In
this work we use inhibitors of phosphoenolpyruvate carboxykinase activity to search for fur-
ther differences between these isoenzymes. On the one hand we have used the well-
known inhibitor 3-mercaptopicolinic acid. Its inhibition patterns were the same for both iso-
enzymes: a three-fold decrease of the Ki values for GTP in 139Met and 139Leu (273 and
873 μM, respectively). On the other hand, through screening of a chemical library we have
found two novel compounds with inhibitory effects of a similar magnitude to that of 3-mer-
captopicolinic acid but with less solubility and specificity. One of these novel compounds,
(N'1-({5-[1-methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl]-2-thienyl}methylidene)-2,4-dichloro-
benzene-1-carbohydrazide), exhibited significantly different inhibitory effects on either iso-
enzyme: it enhanced threefold the apparent Km value for GTP in 139Met, whereas in
139Leu, it reduced it from 99 to 69 μM. The finding of those significant differences in the
binding of GTP reinforces the hypothesis that the Met139Leu substitution affects strongly
the nucleotide binding site of PEPCK-C.
Introduction
Mammalian cytosolic phosphoenolpyruvate carboxykinase (PEPCK-C, EC 4.1.1.32) catalyzes
the GTP-dependent phosphorylation of OAA to yield PEP, GDP and CO2. The reverse reac-
tion is possible, however it is unlikely to occur in vivo because the Km for PEP is higher than its
physiological concentrations [1–2]. PEPCK-C is situated in a crossroad of metabolic pathways;
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it is the main regulatory enzyme of gluconeogenesis and, in some tissues, of glyceroneogenesis.
It also serves as regulator of the tricarboxylic acid cycle and is involved in serine biosynthesis
[3]. Due to its gluconeogenic function, PEPCK-C activity favors pathological processes such as
diabetes and cancer [4–7]. The involvement of PEPCK-C in glyceroneogenesis is convincingly
illustrated by the supermouse generated by Hakimi et al. [8] in which a 100-fold overexpression
of PEPCK-C in striated muscular tissue resulted in a 4-fold enhancement of intramuscular tri-
glyceride content and a concomitant reduction of both visceral and abdominal fat.
We have recently found in pigs two isoforms of PEPCK-C differing in a single amino acid
residue far away from the active center (Met139Leu) and exhibiting reduced and enhanced kcat
values in the gluconeogenic/glyceroneogenic reaction (OAA! PEP) and the reverse one
(PEP! OAA), respectively [9]. Accordingly to the enzyme role in glyceroneogenesis, pigs car-
rying the 139Leu PEPCK-C (the one with lower kcat values in the glyceroneogenic direction)
had lower intramuscular fat content. Other negative phenotypic effects associated to the
Met139Leu substitution in pigs were an increase in backfat thickness and lower meat quality
due to enhanced postmortem exudation. The high frequency of 139Leu PEPCK-C alleles in
modern pig breeds together with the set of negative effects associated to it makes the study of
the pig isoenzymes of considerable economic relevance.
The main regulatory mechanism of PEPCK-C is transcriptional [10–11], although reversible
acetylation of lysine residues has been shown to regulate also PEPCK-C stability in vivo [12].
In spite of its metabolic relevance, no known allosteric effector of PEPCK-C has been found to
be physiologically relevant in vivo. Clearly, finding allosteric effectors of PEPCK-C could be
interesting to modulate its activity in humans. In this respect, PEPCK-C inhibitors could be
alternatives to ameliorate diabetes or to reduce high glucose levels needed by cancer cells [13].
The search for new ligands can focus on structural similarity of ligands with substrates or
can be based on the known 3D structure of the enzyme, especially on its active site [14]. How-
ever, these strategies usually allow the finding of only inhibitors. Several such PEPCK-C inhibi-
tors have been already described, most of which are structural analogues of substrates acting as
competitive inhibitors that bind to the active site and few of them are non-competitive [15–
17]. PEPCK-C inhibitors may help to investigate biochemical or functional differences between
PEPCK-C isoenzymes. Alternatively, enzyme effectors can be identified by screening chemical
libraries, a strategy that is being increasingly used to find molecules with a variety of biological
effects [18–19].
In this work we pursue a double objective: to study more thoroughly the biochemical prop-
erties of pig PEPCK-C isoenzymes using a well-known inhibitor (3-mercaptopicolinic acid,
3-MP) and to identify new PEPCK-C effectors by screening a chemical library against the men-
tioned pig PEPCK-C isoenzymes.
Materials and Methods
2.1. Enzymes and chemicals
Oxaloacetic acid (OAA), GTP, GDP, dithiothreitol (DTT), NADH, HEPES, 8-anilino-
1-naphthalenesulfonic acid (ANS), dimethyl sulfoxide (DMSO), tris-(2-carboxyethyl) phos-
phine (TCEP), mineral oil and enzymes malate dehydrogenase (600–1000 units/mg), pyruvate
kinase (600–1000 units/mL) and lactate dehydrogenase (900–1400 units/mL) were purchased
from Sigma-Aldrich (USA). Phosphoenolpyruvate was obtained from Bachem (Switzerland).
MnCl2, MgCl2 and KHCO3 were acquired from Panreac (Spain). 3-mercaptopicolinic acid
(3-MP) was obtained from Sta. Cruz Biotechnology (USA). A chemical library of 10,000 com-
pounds (HitFinder) and the subsequent positive compounds (N1-cyclohexyl-2-{1-[4-methyl-
2-(2-thienyl)-1,3-thiazol-5-yl]ethylidene}hydrazine-1-carbothiamide, or compound 1, and
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N'1-({5-[1-methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl]-2-thienyl}methylidene)-2,4-dichloro-
benzene-1-carbohydrazide, or compound 2, were purchased fromMaybridge (UK).
2.2. PEPCK-C purification
PEPCK-C 139Met and 139Leu were purified as described in Latorre et al. [9]. In brief, Escheri-
chia coli BL21 (DE3) with the appropriate constructs were grown in LB + ampicillin medium
and then protein expression was induced with IPTG. Clarified bacteria lysates were purified by
affinity chromatography on cobalt column (GE Healthcare). Kinetic assays were performed
with His-tagged PEPCK-C, which behaved almost identically to the non His-tagged enzyme
[2]. For screening, CD spectroscopy and ITC measurements, the His-tag was removed by Pre-
Scission Protease (GE Healthcare) at 4°C overnight.
2.3. Screening of chemical library
PEPCK-C effectors were identified from a chemical library using a screening procedure based
on a thermal-shift assay [20–21]. Potential protein effector compounds were dispensed into
96-well microplates. Each well contained 4 μM PEPCK-C in a 20 mMHEPES buffer pH 7.4,
plus 1 mM TCEP, 100 μMANS, 10% DMSO and either 1 or 5 chemical library compounds,
each at a 25 μM concentration. Previous experiments showed that PEPCK-C tolerates up to
12% DMSO (data not shown). 50 μL of mineral oil were added to each well to prevent evapora-
tion. In a first screening round, 5 different compounds were present in each well. The binding
of effectors to PEPCK-C was assessed by monitoring the thermal denaturation of the enzyme
and identifying compounds inducing a stabilizing effect (increase in the unfolding temperature,
Tm, compared to the free enzyme) in a FluoDia T70 High Temperature Fluorescence Micro-
plate Reader (Photon Technology International, UK). To obtain Tm values, unfolding curves
were fitted to Boltzmann function (Eq 1) using OriginPro 9.1 software.
yðTÞ ¼ A1  A2
1þ exp TTm
S
 þ A2 ð1Þ
where A1 and A2 are the asymptotic values of the signal in the pre- and post-transition region
of the unfolding curve, respectively, and S is a parameter associated with the slope of the
unfolding curve at the Tm and related to the unfolding enthalpy of the enzyme. A given well
was considered as a positive hit if its associated Tm value was 8°C higher than the Tm found in
control wells lacking added library compounds. In a second round, the compounds present in
the positive wells were individually analyzed to identify the binders.
2.4. Enzymatic assays
PEPCK-C activity was measured in an UNICAM 500 spectrometer (UNICAM Analytical Sys-
tems, UK) with coupled spectrophotometric assays using pyruvate kinase and lactate dehydro-
genase as auxiliary enzymes in PEP synthesis reaction and malate dehydrogenase in the reverse
reaction.
Assays to calculate IC50 values were performed in the direction of OAA synthesis in 1 mL of
a 100 mMHEPES buffer pH 7.4, containing 10 mM DTT, 0.2 mMMnCl2, 2 mMMgCl2,
2 mM GDP, 0.2 mM NADH, 2 mM PEP, 100 mM KHCO3 and 4 units of malate dehydroge-
nase. Variable inhibitor concentrations of 0–200 μMwere also used. Assays were initiated by
PEPCK-C addition. Rates were calculated by measuring the decreasing slope of absorbance at
340 nm after subtracting the rate of spontaneous NADH oxidation.
Pig PEPCK-C Isoenzymes Inhibition
PLOS ONE | DOI:10.1371/journal.pone.0159002 July 8, 2016 3 / 17
3-MP inhibitions assays in OAA synthesis direction were carried out as described before
with the exception of the variable substrate (50–600 μM for PEP and 10–100 μM for GDP) and
3-MP concentration (10–100 μM). Assays in the direction of PEP synthesis were performed in
1 mL of a 100 mMHEPES buffer pH 7.4, containing 10 mM DTT, 0.2 mMMnCl2, 2 mM
MgCl2, 1 mM GTP or 400 μMOAA, 1 mM ADP, 0.2 mM NADH, PEPCK-C and 5 units of
each pyruvate kinase and lactate dehydrogenase. Reactions were initiated by addition of OAA.
Variable substrates were 5–50 μMOAA or 25–500 μMGTP and 3-MP concentrations were
between 10–400 μM. Rates were calculated by measuring the decreasing slope at 340 nm of
absorbance after subtracting the rate of spontaneous NADH oxidation in the case of OAA syn-
thesis or the rate of the blank which contained all the components of the mix but PEPCK-C in
the case of PEP synthesis.
To investigate the possible inhibition of auxiliary enzymes by compound 1 and 2 the follow-
ing assay was performed in 1 mL of a 100 mMHEPES buffer pH 7.4, containing 10 mMDTT,
0.2 mMMnCl2, 2 mMMgCl2, 2 mM GDP, 0.2 mM NADH, 2 mM PEP, 1 mM ADP, 100 mM
KHCO3 and 25–200 μM compound 1 or 2. Reactions were initiated by addition of 0.5 units of
each pyruvate kinase and lactate dehydrogenase.
Compound 1 and 2 inhibitions assays were performed in PEP synthesis direction as
described in 3-MP inhibition assays. Variable substrates were 10–100 μMOAA or 25–500 μM
GTP, inhibitors concentrations were around IC50 value (100 μM compound 1 or 50 μM com-
pound 2) and 20 units of each pyruvate kinase and lactate dehydrogenase were also added. The
units of pyruvate kinase and lactate dehydrogenase were increased four times in these assays
due to slight interaction of compounds 1 and 2 with these enzymes.
2.5. Determination of kinetic parameters
IC50 value represents the inhibitor concentration required to reduce activity by 50%. Concen-
tration-dependent inhibition data were fitted to a linear or a quadratic function using Graph-
Pad Prism 3.03 software. 3-MP inhibition assays were fitted in double reciprocal plots. To
describe the mixed non-competitive inhibition, the double reciprocal equation can be written
as:
1
v
¼ Km
Vmax
1þ ½I
Ki
 
1
½S þ
1
Vmax
1þ ½I
aKi
 
ð2Þ
Secondary plots to calculate Ki and αKi values can be constructed from:
Slope ¼ Km
Vmax
þ Km½I
VmaxKi
ð3Þ
Y  intercept ¼ 1
Vmax
þ 1
aKiVmax
½I ð4Þ
Ki and αKi are the dissociation constants of the enzyme-inhibitor complex and the enzyme-
inhibitor-substrate complex, respectively.
Ki values with respect to GTP and GDP were calculated by Dixon plots with all substrates at
saturating concentration because 3-MP produced an uncompetitive inhibition. The equation
for the Dixon plot is:
1
v
¼ Km
Vmax½S
þ 1
Vmax
þ Km
Vmax½SKi
ð5Þ
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Data from compound 1 and 2 inhibition assays were represented in double reciprocal plots
to calculate Vmax and Km values using GraphPad Prism 3.03 software.
2.6. Circular dichroism (CD)
PEPCK-C was diluted to 20 μM in a 20 mMHEPES pH 7.4 buffer, containing 1 mM TCEP.
50 μM 3-MP, compound 1 or compound 2 were added to the PEPCK-C solution. Readings
were performed at 25°C in a 0.1 cm cuvette from 320 to 250 nm in a Chirascan CD-spectro-
photometer (Applied Photophysics, UK). CD spectra were calculated after subtracting the
blank which contained all the components except PEPCK-C.
2.7. Isothermal titration calorimetry (ITC)
Isothermal titration calorimetry (ITC) experiments were performed using an Auto-iTC200
microcalorimeter (MicroCal, Malvern, UK) at 25°C. The reference cell was filled with distilled
water. The sample cell was loaded with 10 μM PEPCK-C 139M or 139L in a 20 mMHEPES
pH 7.4 buffer, containing 150 mMNaCl, 1 mM TCEP and 6.7% DMSO. 2 mM GTP was also
added to the enzyme solution in the corresponding experiments. The syringe was loaded with
400 μM 3-MP or 100 μM compound 2 in a 20 mMHEPES pH 7.4 buffer, containing 150 mM
NaCl, 1 mM TCEP and 6.7% DMSO. In all the assays, a total of 19 injections of 2 μL were
added sequentially to the sample cell with a 150 s spacing to ensure that the thermal power sig-
nal returned to the baseline prior to the next injection. The binding isotherms (normalized
heat effect as a function of the molar ratio) were analyzed with Origin 7 (OriginLab) using a
single class of binding sites model. Calorimetric assays were perform in duplicates at least.
2.8. Statistical analysis
Comparisons between 139Met and 139Leu Ki and between 139Met and 139Leu αKi in 3-MP
kinetics were performed using two-sample t-tests. p<0.05 was considered statistically signifi-
cant. Compound 1 and 2 kinetic experiments were also analyzed using two-sample t-tests com-
paring 139Met and 139Leu Km at the same inhibition range (0 or 50 μM) and 139Met and
139Leu Vmax at the same inhibition range (0 or 50 μM). p<0.05 was considered statistically
significant.
Results
3.1. Inhibition with 3-MP
To investigate the biochemical properties of porcine PEPCK-C isoenzymes we used a well-
known PEPCK-C inhibitor, 3-MP. We first determined IC50 values of wild type PEPCK-C at
saturating substrate concentration in the direction of OAA synthesis. An IC50 value of
65 ± 6 μMwas found (S1 Fig). This value is useful to select the inhibitor concentration range in
further kinetic experiments.
We then studied the inhibition patterns by 3-MP of the two PEPCK-C isoenzymes.
The patterns were different for the two substrates of the reverse reaction (OAA synthesis);
whereas 3-MP behaved as a mixed non-competitive inhibitor when PEP was used as variable
substrate, it behaved as an uncompetitive inhibitor when GDP was used as a variable substrate
(Fig 1 and S2 Fig).
When the effect of 3-MP was studied on the glyceroneogenic reaction, the inhibition pat-
terns were exactly the same as the observed in the reverse reaction; 3-MP behaved as an
uncompetitive inhibitor when using a nucleotide (GTP in this case) as a variable substrate and
Pig PEPCK-C Isoenzymes Inhibition
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as a mixed non-competitive inhibitor when using OAA as a variable substrate (Fig 2 and S3
Fig).
We found no significant differences between 139Met and 139Leu in the reverse reaction.
PEP Ki values were 16 ± 2 μM and 19 ± 4 μM and αKi values were 20 ± 4 μM and 31 ± 5 μM
for 139Met and 139Leu, respectively. Ki values with respect to GDP were 45 μM for both
isoenzymes.
Ki values for glyceroneogenic substrates showed significant differences: they were 3 and 1.6
fold lower for 139Met when using GTP and OAA as variable substrates, respectively. However,
Fig 1. Double reciprocals and secondary plots of 3-MP adding PEP and GDP as variable substrates. (A-C) Double reciprocal, slopes and intercepts of
139Met varying PEP. (D-F) Double reciprocal, slopes and intercepts of 139Leu varying PEP. (G) Double reciprocal of 139Met varying GDP. (H) Double
reciprocal of 139Leu varying GDP. 139Met and 139Leu were assayed as described in Materials and Methods with increasing concentration of substrates
(50–600 μM for PEP, 10–100 μM for GDP) and 3-MP concentration between 10–100 μM.
doi:10.1371/journal.pone.0159002.g001
Pig PEPCK-C Isoenzymes Inhibition
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αKi value with respect to OAA showed no significant differences. All the Ki and αKi values are
presented in Table 1.
3.2. Screening of chemical library
To search for new PEPCK-C effectors we used a 10,000-compound chemical library fromMay-
bridge and the 139Met enzyme. Initial screening was performed using 5 compounds per well.
Afterwards, compounds in positive wells were analyzed individually. A change in unfolding
temperature, measured by fluorescence, was used as indicator for a positive hit (see Fig 3). In
Fig 2. Double reciprocals and secondary plots of 3-MP adding OAA and GTP as variable substrates. (A-C) Double reciprocal, slopes and intercepts of
139Met varying OAA. (D-F) Double reciprocal, slopes and intercepts of 139Leu varying OAA. (G) Double reciprocal of 139Met varying GTP. (H) Double
reciprocal of 139Leu varying GTP.139Met and 139Leu were assayed as described in Materials and Methods with increasing concentration of substrates (5–
50 μM for OAA, 25–500 μM for GTP) and 3-MP concentration between 10–100 μM for OAA and between 50–400 μM for GTP.
doi:10.1371/journal.pone.0159002.g002
Pig PEPCK-C Isoenzymes Inhibition
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the first round 7 hits were identified with Tm values of 55.5 ± 0.1, 56.4 ± 0.3, 48.1 ± 0.1,
53.9 ± 0.2, 56.9 ± 0.2, 53.0 ± 0.3 and 52.6 ± 0.1°C, well above the unfolding temperature deter-
mined in control wells (41.8 ± 0.1°C).
The 35 compounds contained in the 7 positive wells of the first screening were then ana-
lyzed individually. In this screening we found only two hits with Tm values of 50.9 ± 0.1 and
50.0 ± 0.1, which is about 8°C higher than controls. The absence of positive hits in the remain-
der wells can be attributed to a previous accumulative stabilizing effect of the compounds in
the initial positive wells or just be false positives.
The identified compounds were N1-cyclohexyl-2-{1-[4-methyl-2-(2-thienyl)-1,3-thiazol-
5-yl]ethylidene}hydrazine-1-carbothiamide, or compound 1, and N'1-({5-[1-methyl-5-(tri-
fluoromethyl)-1H-pyrazol-3-yl]-2-thienyl}methylidene)-2,4-dichlorobenzene-1-carbohydra-
zide, or compound 2 (Fig 4). Compounds 1 and 2 were selected for subsequent kinetic analysis.
3.3. Inhibition with compound 1
We first calculated IC50 values at saturating substrate concentrations assaying the activity in
the direction of OAA synthesis. Compound 1 showed an IC50 value of 134 ± 4 μM (S4 Fig).
This value was higher than that obtained for 3-MP (65 ± 6 μM. Concentrations above 250 μM
resulted in precipitation of compound 1 due to its poor solubility. Compound 1 additionally
showed a slight inhibition of the auxiliary enzymes pyruvate kinase and lactate dehydrogenase
(data not shown), which was solved by increasing four times the concentration of the auxiliary
enzymes. Due to the mentioned low solubility problems we decided to perform for compound
1 a more simple analysis of inhibition than the one performed with 3-MP. We calculated only
Table 1. Ki and αKi values and inhibition patterns of PEPCK-C isoenzymes in presence of 3-MP.
PEP GDP OAA GTP
Ki (μM) αKi (μM) Pattern of
inhibition
Ki (μM) Pattern of
inhibition
Ki (μM) αKi (μM) Pattern of
inhibition
Ki (μM) Pattern of
inhibition
139Met 16 ± 2 20 ± 4 Mixed NC 45 ± 3 Uncompetitive 18 ± 4 49 ± 18 Mixed NC 273 ± 68 Uncompetitive
139Leu 19 ± 4 ns 31 ± 5 ns Mixed NC 45 ± 0.8 ns Uncompetitive 29 ± 1 * 21 ± 13 ns Mixed NC 873 ± 144 ** Uncompetitive
Values given are the mean ± SD. Differences were calculated using two-sample t-test; ns: no significant,
* p< 0.05,
** p< 0.01.
NC: Non-Competitive
doi:10.1371/journal.pone.0159002.t001
Fig 3. Thermal unfolding of PEPCK-C in presence and absence of compound 1 or 2.
doi:10.1371/journal.pone.0159002.g003
Pig PEPCK-C Isoenzymes Inhibition
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the change in Vmax and Km values, instead of Ki values, using an inhibitor concentration
around its IC50.
When using OAA as variable substrate we found a drop in Vmax value (from 21.3 to
6.7 μmol min-1 mg-1 in 139Met and from 21.8 to 9.4 μmol min-1 mg-1 in 139Leu) and no
Fig 4. Structural formula of compounds 1 and 2.
doi:10.1371/journal.pone.0159002.g004
Fig 5. Double reciprocal plots of compound 1 inhibition varying glyceroneogenic substrates.
doi:10.1371/journal.pone.0159002.g005
Pig PEPCK-C Isoenzymes Inhibition
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change in Km (Fig 5). There were no significant differences in Vmax or Km between 139Met and
139Leu (Table 2).
Nevertheless, when GTP was used as variable substrate Vmax values were reduced from 20.0
to 7.8 μmol min-1 mg-1 and from 22.5 to 7.2 μmol min-1 mg-1 for 139Met and 139Leu, respec-
tively. Km values raised from 96 and 99 to 118 and 155 μM in 139Met and 139Leu, respectively.
There were also no significant differences between PEPCK-C isoenzymes (Table 2).
3.4. Inhibition with compound 2
IC50 value for compound 2 was 30 ± 2 μM (S4 Fig). This value was lower than those of 3-MP
(65 ± 6 μM) or compound 1 (134 ± 4 μM). Compound 2 also presented poor solubility and a
slight interaction with auxiliary enzymes, what made necessary a four-fold increase in the
amount of auxiliary enzymes added to the assays.
Vmax values for OAA in the presence of the inhibitor were reduced from 21.3 to 4.6 μmol
min-1 mg-1 in the case of 139Met and from 21.8 to 12.7 μmol min-1 mg-1 in the case of 139Leu.
This change was significantly different between 139Met and 139Leu, the former isoform being
more sensitive to inhibition by compound 2. Km values remained constant (Fig 6).
When using GTP as a variable substrate, we found significant differences between isoen-
zymes: whereas 139Met Km value was raised in the presence of the inhibitor over 2.5 fold,
139Leu Km value was reduced by about 30% (see Table 3). No significant change was observed
in the effect of compound 2 on Vmax values of 139Met and 139Leu.
3.5. CD spectra
The near UV-CD spectra of a protein arises from contributions of aromatic residues in asym-
metric environments, which is characteristic of native protein conformations [22], and it is
very sensitive to small changes such as the binding of compounds near those aromatic residues.
Therefore modifications of the near-UV CD spectrum of a protein in presence of a given com-
pounds reveals binding. However, the reverse needs not be necessarily true, because binding
can occur far away from contributing aromatic residues. To find further proof that 3-MP, com-
pound 1 and compound 2 bind to PEPCK-C, the near-UV CD spectra of the enzymes in pres-
ence of those compounds were recorded. As can be seen in Fig 7, 3-MP and more markedly
compound 2 modify the CD spectra of both isoenzymes. However, there were no clear differ-
ences in the enzyme CD spectra when 50 μM (Fig 7C and 7D) or 150 μM (data not shown) of
compound 1 was added to a PEPCK-C solution. This may be indicative of, although it does not
prove it, a weaker binding of compound 1 to PEPCK-C, compared to 3-MP and compound 2,
as additionally suggested by its weaker inhibitory effect.
Table 2. Vmax andKm values and inhibition patterns of PEPCK-C isoenzymes in the presence of glyceroneogenic substrates and compound 1.
[Compound 1] (μM) OAA GTP
Vmax (μmol min-1 mg-1) Km (μM) Vmax (μmol min-1 mg-1) Km (μM)
139Met 0 μM 21.3 ± 3.7 22 ± 14 20.0 ± 1.9 96 ± 15
139Met 50 μM 6.7 ± 1.4 13 ± 5 7.8 ± 0.5 118 ± 14
139Leu 0 μM 21.8 ± 1.8 ns 14 ± 4 ns 22.5 ± 4.2 ns 99 ± 14 ns
139Leu 50 μM 9.4 ± 1.3 ns 11 ± 3 ns 7.2 ± 0.4 ns 155 ± 30 ns
Values given are the mean of three independent experiments ± SD. Differences in Vmax and Km between 139Met and 139Leu were calculated using two-
sample t-test; ns: not significant.
doi:10.1371/journal.pone.0159002.t002
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3.6. Isothermal titration calorimetry (ITC)
In order to prove that Met139Leu substitution and the inhibitor binding affects the nucleotide
binding site, we performed ITC experiments in the presence or the absence of nucleotide. The
results of these experiments are shown in Fig 8 and the derived thermodynamic parameters are
Fig 6. Double reciprocal plots of compound 2 inhibition varying glyceroneogenic substrates.
doi:10.1371/journal.pone.0159002.g006
Table 3. Vmax andKm values and inhibition patterns of PEPCK-C isoenzymes in the presence of glyceroneogenic substrates and compound 2.
[Compound 2] (μM) OAA GTP
Vmax (μmol min-1 mg-1) Km (μM) Vmax (μmol min-1 mg-1) Km (μM)
139Met 0 μM 21.3 ± 3.7 22 ± 14 20.0 ± 1.9 96 ± 15
139Met 50 μM 4.6 ± 1.4 32 ± 19 5.9 ± 2.3 276 ± 37
139Leu 0 μM 21.8 ± 1.8 ns 14 ± 4 ns 22.5 ± 4.2 ns 99 ± 14 ns
139Leu 50 μM 12.7 ± 1.1 ** 12 ± 4 ns 6.1 ± 1.0 ns 69 ± 10 ***
Values given are the mean of three independent experiments ± SD. Differences in Vmax and Km between 139Met and 139Leu were calculated using two-
sample t-test;
ns: not significant,
** p< 0.01
*** p< 0.001
doi:10.1371/journal.pone.0159002.t003
Pig PEPCK-C Isoenzymes Inhibition
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summarized in Table 4. We have compared 139Met and 139Leu, 3-MP and compound 2, both
in the presence and the absence of GTP. We have chosen GTP because the kinetic differences
between isoenzymes were larger with GTP than with GDP.
The dissociation constant (Kd) describes the affinity between a protein and a ligand. In all
experiments, the Met139Leu substitution reduces the affinity of the inhibitors (Table 4). In the
case of 3-MP, Kd values are 7.2 μM and 12 μM for 139Met and 139Leu, respectively, whereas in
the case of compound 2 Kd values are 4.4 μM for 139Met and 9.8 for 139Leu. The presence of
Fig 7. Near-UV CD spectra of PEPCK-C isoenzymes. 50 μM 3-MP (A-B), compound 1 (C-D) or compound 2 (E-F) were added to 20 μMPEPCK-C in a 20
mMHEPES pH 7.4 buffer and 1 mM TCEP.
doi:10.1371/journal.pone.0159002.g007
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Fig 8. ITCmeasurements of PEPCK-C isoenzymes with 3-MP or compound 2. The upper part of each panel shows the thermogram after baseline
correction, and the lower part shows the binding isotherm with the fit to a single class of binding sites model. (A) 139Met with 3-MP. (B) 139Met with
compound 2.
doi:10.1371/journal.pone.0159002.g008
Table 4. ITC derived thermodynamic parameters.
Kd (μM) ΔH (kcal/mol) n
139Met 3-MP -GTP 7.2 -20.4 2.0
3-MP +GTP 19 -31.8 2.1
C2 -GTP 4.4 -20.5 1.2
C2 +GTP 19 -26.6 1.1
139Leu 3-MP -GTP 12 -32.6 2.1
3-MP +GTP 39 -58.2 2.1
C2 -GTP 9.8 -16.7 1.2
C2 +GTP 14 -13.9 1.2
Relative error in Kd is 20%, absolute error in ΔH is 0.6 kcal/mol, and absolute error in n is 0.1.
doi:10.1371/journal.pone.0159002.t004
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GTP further reduces the affinity of the 3-MP (19 μM for 139Met and 39 μM for 139Leu). Nev-
ertheless, the presence of GTP raises the affinity of the compound 2 (19 μM for 139Met and
14 μM for 139Leu), although Kd values are different in presence and absence of GTP.
Enthalpy (ΔH) follows the same pattern of differences showed in Kd values. The negative
enthalpy produced in all experiments showed that the binding of 3-MP and compound 2 are
enthalpically driven.
There are clear-cut differences in the stoichiometry parameter (n) between 3-MP and com-
pound 2 binding. The n values for 3-MP are around 2 and for compound 2 are close to 1. This
indicates that there exist only one binding site for compound 2 in both isoenzymes but two
binding sites for 3-MP, also in both isoenzymes.
Discussion
In a previous work [9] we found two isoenzymes in porcine PEPCK-C that differed consider-
ably in their kinetic and functional properties. Those differences were translated into consider-
able differences in pig and pork phenotypic traits of considerable economic relevance. In this
work we have continued the biochemical characterization of both isoenzymes and we have
used them as a model system to search for new inhibitors able to modulate PEPCK-C activity
due to the relevance of PEPCK-C activity in pathological processes.
To further investigate the catalytic differences between PEPCK-C isoenzymes 139Met and
139Leu we decided to use a known inhibitor, 3-MP, one of the first specific inhibitors of
PEPCK-C described [15]. In our previous work [9], the largest kinetic differences between pig
isoenzymes were detected in their interaction with nucleotides; here again both isoenzymes
show the largest differences when the inhibition is studied varying a nucleotide, GTP. This
means that the Met139Leu substitution affects probably the structure of the enzyme active site
around the nucleotide binding site.
We have found the rather uncommon uncompetitive inhibition pattern of both PEPCK-C
isoenzymes when both nucleotides (GDP and GTP) were used as variable substrate. This inhi-
bition pattern requires a prior binding of the substrate to the active site in order to make the
inhibitor site accessible. Recently, Balan et al. [23] found a very similar result studying the inhi-
bition of rat PEPCK-C by 3-MP using both kinetic experiments and the determination of the
3D structure of the protein with bound 3-MP. They find uncompetitive inhibition when using
GDP or GTP as variable substrates. However, their structural determinations showed that
3-MP had two binding sites: one in the active site that was responsible for the competitive com-
ponent of their kinetic experiments, and the other one close to the active site and able to influ-
ence allosterically the binding of substrates and inhibitors to the active site. These structural
data are not compatible with the apparent uncompetitive character of 3-MP inhibition because
uncompetitive inhibition requires the existence of independent (or different) substrate and
inhibitor binding sites [24]. Balan et al. [23] explain their results suggesting that the anomalous
uncompetitive inhibition detected by kinetic means is due to the communication between the
allosteric inhibitor site and the active site. Whatever is the true nature of the inhibition by
3-MP, this inhibitor serves to demonstrate the existence of further biochemical differences
between pig PEPCK-C isoenzymes because the comparison of Ki values for 3-MP in the pres-
ence of GTP showed strong differences between pig isoenzymes. 139Met has an almost three
fold larger affinity for 3-MP than 139Leu (273 vs 873 μM). We found no difference between
PEPCK-C isoenzymes when analyzing 3-MP effects on PEP binding and only slight ones when
analyzing its effects on OAA binding (Ki for139Leu is 50% larger than for 139Met). The inhibi-
tion mode for PEP and OAA was the same for both isoenzymes and substrates, a mixed non-
competitive one.
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The screening of the chemical library with 10,000 compounds yielded two positive com-
pounds that stabilize the enzyme increasing the Tm around 8°C. The positive compounds were
N1-cyclohexyl-2-{1-[4-methyl-2-(2-thienyl)-1,3-thiazol-5-yl]ethylidene}hydrazine-1-car-
bothiamide, or compound 1, and N'1-({5-[1-methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl]-
2-thienyl}methylidene)-2,4-dichlorobenzene-1-carbohydrazide, or compound 2.
In general, the effects of both compound 1 and 2 on Vmax are stronger than on Km values,
which suggests that their inhibition mode is different from that of 3-MP and that they could
have a different binding site than 3-MP. On the other hand, the structural similarity of com-
pounds 1 and 2 (Fig 4) suggest these two compounds may share a common binding site.
There were quantitative differences between the inhibitory effects of compound 2 on
139Met and 139Leu: using OAA as a variable substrate, Vmax values were 4.6 and 12.7 μmol
min-1 mg-1 for 139Met and 139Leu, respectively. This significant difference showed that
139Met was more sensitive to compound 2 than 139Leu. Another significant difference when
using GTP as a variable substrate was that Km value of 139Met raised 2.5-fold in presence of
compound 2, whereas 139Leu Km decreased around 30%. As we report with 3-MP, compound
2 constitutes a valuable tool to investigate the biochemical differences between pig isoenzymes.
The results found in the ITC experiments show again differences between PEPCK-C isoen-
zymes when analyzing GTP binding. As it happened in the kinetic experiments (see Table 1),
Kd for 3-MP of 139Met was much lower than that of 139Leu (19 vs 39 μM) in the presence of
GTP, which resembles the effects found on Ki values in the kinetic experiments. ITC experi-
ments showed also very different stoichiometry when studying 3-MP and compound 2 bind-
ing. Whereas n was 1 in all experiments using compound 2, we found a value of 2 when using
3-MP. As this parameter reflects the number of binding sites, our results suggest that there is
only one binding site for compound 2 but two sites for 3-MP, in agreement with two 3-MP
binding sites reported in the crystallographic structure of rat PEPCK-C by Balan et al. [23].
The study by ITC of compound 2 binding resembles also the kinetic results (see Table 3):
the affinity of the 139Met isoenzyme (19 μM) for compound 2 in the presence of GTP is
slightly lower than that of the 139Leu isoenzyme (14 μM).
The existence of notable differences between Kd values for both isoenzymes in the presence
and in the absence of GTP (Table 4) confirms that both inhibitors affect the nucleotide binding
site. The sites of 3-MP binding have been already determined by Balan et al. [23]; our results
with compound 2 do not allow us to specify where the binding site for this inhibitor is located.
Most PEPCK-C effectors described in the literature are substrate analogues acting mainly as
competitive inhibitors [15]. Finding new PEPCK-C inhibitors is important because of the
PEPCK-C role in diabetes and cancer. PEPCK-C has been identified as a major contributing
factor for the appearance of diabetes mellitus type 2 [25]. Cancer cells may overexpress
PEPCK-C to avoid the decreased levels of glucose due to the preponderance of glycolysis in
tumor areas [6]. New effectors with different patterns of inhibition could be interesting due to
the potential existence of synergistic effects between inhibitors with different binding sites.
IC50 values of compounds 1 and 2 are rather low which means that these inhibitors could be
used as in vivo effectors. However, their poor solubility and their slight interaction with auxil-
iary enzymes indicate that compounds 1 and 2 are not very selective inhibitors and that they
would need some improvement before they can be used as in vivo PEPCK-C effectors. Directed
chemical modification of compounds 1 or 2 to improve their solubility and specificity could
yield suitable effectors against diabetes or cancer.
In conclusion, the use of inhibitors reveals further biochemical differences between pig
PEPCK-C isoenzymes reinforcing the idea that the Met139Leu substitution affects mainly the
GTP/GDP binding site. The new PEPCK-C inhibitors found in this study could be helpful to
modulate PEPCK-C activity in vivo if their solubility and selectivity could be improved.
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Supporting Information
S1 Fig. Concentration-dependent inhibition of PEPCK-C by 3-MP. Data are the mean of
three independent experiments ± SD.
(TIF)
S2 Fig. Dixon plots of 3-MP adding PEP and GDP as variable substrates. (A) Dixon plot of
139Met varying PEP. (B) Dixon plot of 139Leu varying PEP. (C) Dixon plot of 139Met at satu-
rating concentration of GDP. (D) Dixon plot of 139Leu at saturating concentration of GDP.
(TIF)
S3 Fig. Dixon plots of 3-MP adding OAA and GTP as variable substrates. (A) Dixon plot of
139Met varying OAA. (B) Dixon plot of 139Leu varying OAA. (C) Dixon plot of 139Met at sat-
urating concentration of GTP. (D) Dixon plot of 139Leu at saturating concentration of GTP.
(TIF)
S4 Fig. Concentration-dependent inhibition of PEPCK-C by compounds 1 and 2. Data are
the mean of three independent experiments ± SD. Compound 1 plot (A) was adjusted to linear
regression due to its precipitation above 200 μM.
(TIF)
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